Katherine Stueland - Sep 30, 2025 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Bridget Brown, Attorney-in-Fact
Stock symbol
WGS
Transactions as of
Sep 30, 2025
Transactions value $
-$1,390,911
Form type
4
Date filed
10/1/2025, 04:21 PM
Previous filing
Sep 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stueland Katherine CHIEF EXECUTIVE OFFICER, Director C/O GENEDX HOLDINGS CORP., STAMFORD /s/ Bridget Brown, Attorney-in-Fact 2025-10-01 0001689575

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Sale -$63.7K -606 -4.16% $105.10 14K Sep 30, 2025 Direct F1, F2
transaction WGS Class A Common Stock Sale -$117K -1.09K -7.82% $106.69 12.9K Sep 30, 2025 Direct F1, F3
transaction WGS Class A Common Stock Sale -$480K -4.46K -34.64% $107.61 8.42K Sep 30, 2025 Direct F1, F4
transaction WGS Class A Common Stock Sale -$560K -5.16K -61.33% $108.55 3.26K Sep 30, 2025 Direct F1, F5
transaction WGS Class A Common Stock Sale -$60.5K -554 -17.02% $109.13 2.7K Sep 30, 2025 Direct F1, F6
transaction WGS Class A Common Stock Sale -$22K -200 -7.4% $110.23 2.5K Sep 30, 2025 Direct F1
transaction WGS Class A Common Stock Sale -$72.1K -645 -25.79% $111.84 1.86K Sep 30, 2025 Direct F1, F7
transaction WGS Class A Common Stock Sale -$15.5K -136 -7.33% $113.68 1.72K Sep 30, 2025 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.98 to $105.558, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 7.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.98, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.9955, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.00 to $108.99, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.00 to $109.3837, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.50 to $112.04, inclusive.
F8 Following the reported sales effectuated pursuant to a 10b5-1 plan, in addition to the 1,720 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 444,539 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms.